Discovery of new antibacterials with novel mechanisms is important to counteract the ingenious resistance mechanisms of bacteria. In this connection, omics-guided drug discovery offers a rigorous method in the quest of new antibacterials. (-)-Roemerine is a plant alkaloid that has been reported to possess putative antibacterial activity against Escherichia coli, Bacillus subtilis, and Salmonella typhimurium. The aim of the present study was to characterize the activity of (-)-roemerine in Escherichia coli TB1 using proteomics tools. With (-)-roemerine treatment, we found limited permeability through the outer membrane and repression of transport proteins involved in carbohydrate metabolism, resulting in poor carbon source availability. The shortfall of intracellular carbon sources in turn led to impaired cell growth. The reduction in the abundance of proteins related to translational machinery, amino acid biosynthesis, and metabolism was accompanied by a nutrient-limited state. The latter finding could suggest a metabolic shutdown in E. coli cells. High osmolarity was clearly not one of the reasons of bacterial death by (-)-roemerine. These observations collectively attest to the promise of plant omics and profiling of putative drug candidates using proteomics tools. Omics-guided drug discovery deserves greater attention in mainstream pharmacology so as to better understand the plants' medicinal potentials.
Get full access to this article
View all access options for this article.
References
1.
AbreuAC, McBainAJ, and SimoesM. (2012). Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep, 29, 1007–1021.
2.
AgnihotriVK, El SohlyHN, KhanSI, et al. (2008). Constituents of Nelumbo nucifera leaves and their antimalarial and antifungal activity. Phytochem Lett, 1, 89–93.
3.
AmsterdamD. (1996). Susceptibility testing of antimicrobials in liquid media. In: LomanV. (ed), Antibiotics in Laboratory Medicine. Williams and Wilkins, Baltimore, pp. 52–111.
4.
BaghdikianB, Mahiou-LeddetV, BoryS, et al. (2013). New antiplasmodial alkaloids from Stephaniarotunda. J Ethnopharmacol, 145, 381–385.
5.
BaldwinEL, and OsheroffN. (2005). Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents, 5, 363–372.
6.
BandowJE, BrötzH, LeichertLI, LabischinskiH, and HeckerM. (2003). Proteomic approach to understanding antibiotic action. Antimicrob Agents Chemother, 47, 948–955.
7.
BeacheyEH, GiampapaCS, and AbrahamSN. (1988). Bacterial adherence. Adhesin receptor-mediated attachment of pathogenic bacteria to mucosal surfaces. Am Rev Respir Dis, 138, S45–48.
8.
BhadraK, and KumarGS. (2011). Therapeutic potential of nucleic acid-binding isoquinoline alkaloids: Binding aspects and implications for drug design. Med Res Rev, 31, 821–862.
9.
BinitaK, KumarS, SharmaVK, SharmaV, and YadavS. (2014). Proteomic identification of Syzygium cumini seed extracts by MALDI-TOF/MS. Appl Biochem Biotechnol, 172, 2091–2105.
10.
BjellqvistB, EkK, RighettiPG, GianazzaE, GörgA, WestermeierR, and PostelW. (1982). Isoelectric focusing in immobilized pH gradients: Principle, methodology and some applications. J Biochem Biophys Met, 6, 317–339.
11.
BlattnerFR, PlunkettG3rd, BlochCA, et al. (1997). The complete genome sequence of Escherichia coli K-12. Science, 277, 1453–1462.
12.
BoberekJM, StachJ, and GoodL. (2010). Genetic evidence for inhibition of bacterial division protein FtsZ by berberine. PLoS One, 5, e13745.
13.
BockstaelK, and AerschotAV. (2009). Antimicrobial resistance in bacteria. Cent Eur J Med, 4, 141–155.
BradfordMM. (1976). A rapid and sensitive method for the quantitation of microgram of protein utilizing the principle of protein-dye binding. Anal Biochem, 12, 248–254.
16.
BringerMA, RolhionN, GlasserAL, and Darfeuille-MichaudA. (2007). The oxidoreductase DsbA plays a key role in the ability of the Crohn′s disease associated adherent-invasive Escherichia coli strain LF82 to resist macrophage killing. J Bacteriol, 189, 4860–4871.
17.
Brötz-OesterheltH, BandowJE, and LabischinskiH. (2005). Bacterial proteomics and its role in antibacterial drug discovery. Mass Spectrom Rev, 24, 549–565.
18.
BukauB, EhrmannM, and BoosW. (1986). Osmoregulation of the maltose regulon in Escherichia coli. J Bacteriol, 166, 884–891.
19.
ChristophersonMR, SchmitzGE, and DownsDM. (2008). YjgF is required for isoleucine biosynthesis when Salmonella enterica is grown on pyruvate medium. J Bacteriol, 190, 3057–3062.
20.
ChuliaS, IvorraMD, CaveA, CortesD, NogueraMA, and D'OconMP. (1995). Relaxant activity of three aporphine alkaloids from Annona cherimolia on isolated aorta of rat. J Pharm Pharmacol, 47, 647–650.
21.
CrespoMD, PuorgerC, SchärerMA, EidamO, GrütterMG, CapitaniG, and GlockshuberR. (2012). Quality control of disulfide bond formation in pilus subunits by the chaperone FimC. Nat Chem Biol, 8, 707–713.
22.
CroteauR, KutchanTM, and LewisNG. (2000). In: Natural Products (Secondary Metabolites): Biochemistry and Molecular Biology of Plants (BuchananB., GruissemW., JonesR., Eds.), American Society of Plant Physiologists, Maryland; Chapter 24, pp. 1250–1318.
23.
DengYC, LiJR, GaoCW, and YangLL. (2006). Inhibitory activity of the extract from the root tubers of Stephania kwangsiensis and its compounds against pathogenic fungi and bacteria. Plant Prot, 32, 43–46.
24.
DenoncinK, and ColletJ-F. (2013). Disulfide bond formation in the bacterial periplasm: Major achievements and challenges ahead. Antioxid Redox Signal, 19, 63–71.
25.
DonnellyMR, and CiborowskiP. (2015). Proteomics, biomarkers and HIV-1: A current perspective. Proteomics Clin Appl. doi: 10.1002/prca.201500002.
26.
DoyleAE, McQueenEG, and SmirkFH. (1955). Treatment of hypertension with reserpine, with reserpine in combination with pentapyrrolidinium, and with reserpine in combination with Veratrum alkaloids. Circulation, 11, 170–181.
27.
DupontM, DéE, CholletR, ChevalierJ, and PagèsJM. (2004). Enterobacter aerogenes OmpX, a cation-selective channel mar- and osmo-regulated. FEBS Lett, 569, 27–30.
28.
DupontM, JamesCE, ChevalierJ, and PagèsJM. (2007). An early response to environmental stress involves regulation of OmpX and OmpF, two enterobacterial outer membrane pore-forming proteins. Antimicrob Agents Chemother, 51, 3190–3198.
29.
EastSP, and SilverLL. (2013). Multitarget ligands in antibacterial research: Progress and opportunities. Expert Opin Drug Discov, 8, 143–156.
30.
ForchhammerK.(2007). Glutamine signalling in bacteria. Front Biosci, 12, 358–370.
31.
ForstS, DelgadoJ, and InouyeM. (1989). Phosphorylation of OmpR by the osmosensor EnvZ modulates expression of the ompF and ompC genes in Escherichia coli. Proc Natl Acad Sci USA, 86, 6052–6056.
32.
FranceschiniA, SzklarczykD, FrankildS, et al. (2013). STRING v9.1: Protein–protein interaction networks, with increased coverage and integration. Nucleic Acids Res, 41, D808–815.
33.
GooleyAA, and PackerNH. (1997). The importance of protein co- and post-translational modifications in proteome projects. Principles and Practice. In: WilkinsMR, WilliamsKL, AppelRD, and HochstrasserDF. (ed.), Proteome Research: New Frontiers in Functional Genomics. Springer, Berlin, Germany; pp. 65–91.
34.
HeebS, FletcherMP, ChhabraSR, DiggleSP, WilliamsP, and CamaraM. (2011). Quinolones: From antibiotics to autoinducers. FEMS Microbiol Rev, 35, 247–274.
35.
HenebergP. (2009). Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs. Curr Med Chem, 16, 706–733.
36.
Hengge-AronisR, KleinW, LangeR, RimmeleM, and BoosW. (1991). Trehalose synthesis genes are controlled by the putative sigma factor encoded by rpoS and are involved in stationary-phase thermotolerance in Escherichia coli. J Bacteriol, 173, 7918–7924.
37.
HerasB, ShouldiceSR, TotsikaM, ScanionMJ, SchemberiMA, and MartinJL. (2009). DSB proteins and bacterial pathogenicity. Nat Rev Microbiol, 7, 215–225.
38.
HoehamerCF, CummingsED, HillardGM, and RogersPD. (2010). Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents. Antimicrob Agents Chemother, 54, 1655–1664.
39.
KaraosmanogluK, SayarNA, KurnazIA, and AkbulutBS. (2014). Assessment of berberine as a multi-target antimicrobial: A multi-omics study for drug discovery and repositioning. OMICS J Integr Biol, 18, 42–53.
40.
KashiwadaY, AoshimaA, IkeshiroY, et al. (2005). Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of Nelumba nucifera, and structure-activity correlations with related alkaloids. Bioorg Med Chem, 13, 443–448.
41.
KittakoopP, MahidolC, and RuchirawatS. (2014). Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation. Curr Top Med Chem, 14, 239–252.
42.
KobayashiY, YamashitaY, FujiiN, et al. (1995). Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes. Planta Med, 61, 414–418.
43.
KoebnikR, LocherKP, and van GelderP. (2000). Structure and function of bacterial outer membrane proteins: Barrels in a nutshell. Mol Microbiol, 37, 239–253.
44.
LinY-L, ChenY-S, HsuY-M, YaoC-H, and ChangT-J. (2012). Proteomic analysis and antibacterial effects of Lithospermi radix against common bacteria form human infected wounds. Biomed Eng Appl Basis Commun, 24, 37.
45.
LiouY-F, LinK-H, and LuS-T. (1979). Screening for anti-microbial and anti-tumor alkaloids. J Taiwan Pharm Assoc, 31, 28–38.
46.
LipinskiCA, LombardoF, DominyBW, and FeeneyPJ. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev, 46, 3–26.
47.
LivakKJ, and SchmittgenTD. (2001). Analysis of relative gene expression data using real-time quantitive PCR and the 2-ΔΔCT method. Methods, 25, 402–408.
48.
MahendranKR, KreirM, WeingartH, FertigN, and WinterhalterM. (2010). Permeation of antibiotics through Escherichia coli OmpF and OmpC porins: Screening for influx on a single-molecule level. J Biomol Screen, 15, 302–307.
49.
MarionL, and GrassieV. (1944). The synthesis of l-roemerine. J Am Chem Soc, 66, 1290–1292.
50.
MecsasJ, WelchR, EricksonJW, and GrossCA. (1995). Identification and characterization of an outer membrane protein, OmpX, in Escherichia coli that is homologous to a family of outer membrane proteins including Ail of Yersinia enterocolitica. J Bacteriol, 177, 799–804.
51.
Mee-JungH, LeeSY, and HongSH. (2012). Comparative analysis of envelope proteomes in Escherichia coli B and K12 Strains. J Microbiol Biotechnol, 22, 470–478.
52.
MiskiM, ShenX, CooperR, GillumAM, FisherDK, MillerRW, and HigginsTJ. (1995). Aporphine alkaloids, CD45 protein tyrosine phosphatase inhibitors, from Rollinia ulei. Bioorg Med Chem Lett, 5, 1519–1522.
53.
NeuhoffV, AroldN, TaubeD, and EhrhardtW. (1988). Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis, 9, 255–262.
54.
NeyfakhAA, BorschCM, and KaatzGW. (1993). Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob Agents Chemother, 37, 128–129.
55.
NozakaT, WatanabeF, TadakiS, IshinoM, MorimotoI, KunitomoJ, IshiiH, and NatoriS. (1990). Mutagenicity of isoquinoline alkaloids, especially of the aporphine type. Mutat Res, 240, 267–279.
56.
OttoK, and HermanssonM. (2004). Inactivation of ompX causes increased interactions of type 1 fimbriated Escherichia coli with abiotic surfaces. J Bacteriol, 186, 226–234.
57.
OzbalciC, UnsalC, KazanD, and Sariyar-AkbulutB. (2010). Proteomic response of Escherichia coli to the alkaloid extract Papaver polychaetum. Ann Microbiol, 60, 709–717.
58.
PetriWAJr. (2003). Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine?. Trends Pharmacol Sci, 24, 210–213.
59.
RaoAA, PatkariM, ReddyPJ, et al. (2014). Proteomic analysis of Streptomyces coelicolor in response to Ciprofloxacin challenge. J Proteomics, 97, 222–234.
60.
RaoG-X, ZhangS, WangH-M, LiZ-M, GaoS, and XuG-L. (2009). Antifungal alkaloids from the fresh rattan stem of Fibraurea recisa Pierre. J Ethnopharmacol, 123, 1–5.
61.
ReddyPJ, RayS, SatheGJ, PrasadTS, RapoleS, PandaD, and SrivastavaS. (2015). Proteomics analyses of Bacillus subtilis after treatment with plumbagin, a plant-derived naphthoquinone. OMICS J Integr Biol, 19, 12–23.
62.
SahuJ, SenP, ChoudhuryMD, DehuryB, BarooahM, ModiMK, and TalukdarAD. (2014). Rediscovering medicinal plants' potential with OMICS: Microsatellite survey in expressed sequence tags of eleven traditional plants with potent antidiabetic properties. OMICS, 18, 298–309.
63.
SariyarG. (2002). Biodiversity in the alkaloids of Turkish Papaver species. Pure Appl Chem, 74, 557–574.
64.
SariyarG, and KalavYN. (1990). Alkaloids from Papaver rhopalothece used as fold medicine in Anatolia. Planta Med, 56, 232.
65.
SariyarG, and OztekinA. (1981). Sur les alcaloides de Papaver spicatum et de P. strictum (Papaveraceae). Plantes Med Phytothér, 15, 160–166.
66.
SibandaT, and OkohAI. (2007). The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents. Afr J Biotechnol, 6, 2886–2896.
67.
StoorvogelJ, van BusselMJAWM, and van de KlundertJAM. (1987). Cloning of a beta-lactam resistance determinant of Enterobacter cloacae affecting outer membrane proteins of Enterobacteriaceae. FEMS Microbiol Lett, 48, 277–281.
68.
StancikLM, StancikDM, SchmidtB, BarnhartDM, YonchevaYN, and SlonczewskiJL. (2002). pH-dependent expression of periplasmic proteins and amino acid catabolism in Escherichia coli. J Bacteriol, 184, 4246–4258.
69.
TadakiS, NozakaT, YamadaS, IshinoM, MorimotoI, TanakaA, and KunitomoJ. (1992). Clastogenicity of aporphine alkaloids in vitro. J Pharmacobiodyn, 15, 501–512.
70.
TerkeltaubRA, FurstDE, BennettK, KookKA, CrockettRS, and DavisMW. (2010). High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum, 62, 1060–1068.
71.
TranTD, PhamNB, FechnerG, and QuinnRJ. (2010). Chemical investigation of drug-like compounds from the Australian tree, Neolitsea dealbata. Bioorg Med Chem Lett, 20, 5859–5863.
72.
TranQT, PearlsteinRA, WilliamsS, ReillyJ, KruckerT, and ErdemliG. (2014). Structure-kinetic relationship of carbapenem antibacterials permeating through E. coli OmpC porin. Proteins, 82, 2998–3012.
73.
ValienteM, D'OconP, NogueraMA, CasselsBK, LugnierC, and IvvoraMD. (2004). Vascular activity of (-)-anonaine, (-)-roemerine and (-)-pukateine, three natural 6a(R)-1,2-methylenedioxyaporphines with different affinities for alpha 1-adrenoceptor subtypes. Planta Med, 70, 603–609.
74.
VanBogelenRA, SchillerEE, ThomasJD, and NeidhardtFC. (1999). Diagnosis of cellular states of microbial organisms using proteomics. Electrophoresis, 20, 2149–2159.
75.
VeberDF, JohnsonSR, ChengHY, SmithBR, WardKW, and KoppleKD. (2002). Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem, 45, 2615–2623.
76.
VivianJP, ScoullarJ, RimmerK, et al. (2009). Structure and function of the oxidoreductase DsbA1 from Neisseria meningitidis. J Mol Biol, 394, 931–943.
77.
WinkM. (2008). Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. Curr Drug Metab, 9, 996–1009.
78.
WoodJM. (2011). Bacterial osmoregulation: A paradigm for the study of cellular homeostasis. Annu Rev Microbiol, 65, 215–238.
79.
YouM, WickramaratneDB, SilvaGL, et al. (1995). (-)-Roemerine, an aporphine alkaloid from Annona senegalensis that reverses the multidrug-resistance phenotype with cultured cells. J Nat Prod, 58, 598–604.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
